Lakefront Biotherapeutics Advances Gamgertamig After Ouro Deal
MECHELEN, Belgium, August 10, 2026 Lakefront Biotherapeutics NV reported its half-year 2026 financial results and provided a business update...
Biomarkers
Advertisement
Alamar Biosciences Expands Neurodegenerative Disease Partnership
FREMONT, California, August 10, 2026 Alamar Biosciences, Inc. announced an expansion of its strategic partnership with the Alzheimer’s Disease...
BioVie Advances Parkinson’s Program with Phase 2 Success
CARSON CITY, Nev., August 6, 2026 BioVie Inc. announced positive topline results from its Phase 2 SUNRISE-PD trial, demonstrating...
Francis Medical Marks First New York Use of Vanquish System
Lake Success, New York, August 5, 2026 Francis Medical has reached an important commercialization milestone for its Vanquish® Water...
FibroBiologics Secures European Patent for Cartilage Gene Therapy
Houston, Texas, August 5, 2026 FibroBiologics, Inc. has strengthened its global intellectual property portfolio after the European Patent Office...
Advertisements
NIH Expands Human Cancer Models for Precision Oncology
Bethesda, Maryland, August 5, 2026 The National Institutes of Health (NIH), through the National Cancer Institute (NCI) and its...
Lunai Bioworks Expands Parkinson’s AI Drug Discovery Alliance
Sacramento & San Diego, California, August 4, 2026 Lunai Bioworks Inc. has announced a definitive Master Collaboration Agreement with...
Innogen Gains PIC/S GMP Certification for Efsubaglutide
Shanghai, China – August 4, 2026 Innogen Pharmaceuticals has announced that its Efsubaglutide alfa manufacturing facility in Suzhou has...
SOPHiA GENETICS Partners with AstraZeneca on CDx
Boston, Massachusetts & Rolle, Switzerland, August 4, 2026 SOPHiA GENETICS has entered into a global multi-year collaboration with AstraZeneca...
CND Life Sciences Secures Growth Funding for Syn-One Test
Scottsdale, Arizona & Boca Raton, Florida, August 4, 2026 CND Life Sciences has announced the successful completion of a...
Advertisement
